In @Tech_Networks, I explain how #GenomicSequencing can strengthen global surveillance of #AMR and inform pandemic preparedness strategies to contain the spread of resistant infections. 📰
Read the full piece here 👉 https://t.co/4s27XubqH7
#Genomics#PacBio
A third of UK employees resist compulsory office comeback, grumble over 'productivity paranoia' & shoddy tech setups, adding 3.1 extra work weeks per year, unveils new study by Scalable Software. #UKWorkplace#ProductivityParanoia https://t.co/eirbJC8gUJ
The wave of pipeline prioritization initiatives implemented last year has manifested in a jump in terminations of phase 2 clinical trials.
https://t.co/Bh9WTBzIag
Phesi, a provider of patient-centric data analytics, has released the results of its analysis of global clinical trials conducted in 2022. 👇🏻
#biotech#lifesciences#news
https://t.co/M9tkQVbRJt
In GOLD’s new ‘5 minutes with’ series, the team speaks to Gen Li, President, @Phesi_CT, who shares his thoughts on the future of #ClinicalTrials and the very different path he may have taken had he never joined the #PharmaceuticalIndustry.
https://t.co/umpQzjJhRR
#Leadership#AI
But some of the most important applications of collagen are being found outside of the cosmetics world.
When I asked @Phesi_CT to run a search of clinical trials, 95% of collagen research is in various forms of regenerative medicine, from arthritis to wound healing.
🚨New life sciences client alert 🚨 We're excited to announce we are now working with @PacBio to provide PR support, as the company accelerates its EMEA expansion. Check out our blog for further details 👉 https://t.co/NargYgdEvY #pr#content#LifeSciences
How can we unlock the insights held within the genome to improve our understanding of #health and #disease? 🧬
I spoke with @Reece92David at @DDWJournal to explore the scientific breakthroughs made possible with long read sequencing: https://t.co/hIWc1GXBZL
Pistoia Alliance is putting together a new working group that will include liaisons from the FDA’s Center for Drug Evaluation and Research to develop a standardized and shared template for in vitro pharmacology (IVP) data in regulatory submissions.
https://t.co/0xdhwBYTVd
#Biodiversity losses are increasing by the day, and it’s essential we act now to prevent extinctions 🌍
In this @labiotech_eu piece, I go over how @PacBio sequencing can aid species conservation: https://t.co/lMwOfAwRew
#Russia and #Ukraine may not be the central pillars of the global pharmaceutical industry, but that doesn’t mean they aren’t important. We spoke to Gen Li of @Phesi_CT, who have been gathering data on the disruption to clinical trials in the region.
https://t.co/i2Gl27RZl5
A great way to end the week, as we’ve been named as one of the Top Five UK PR Agencies to Work For by @Provoke_News 🎉🎉🎉 We’ll have a blog post next week going into more detail, but we didn’t want to wait to have a celebratory drink 🍾🍷🍹🥃🍺 https://t.co/oQXLkvd1u2 #pr
Today, our experts and #CISOs from @HP, @Siemens and @United will be discussing #cybersecurity challenges of 2021 and looking ahead to the opportunities and threats in the year ahead
“Threat actors have invested in techniques such as email thread hijacking, making it harder than ever for users to tell friend from foe.” – Alex Holland, Senior Malware Analyst at HP
Find out more about emerging #malware techniques in @TechRadarPro
Excited to announce that we are working with @PolyCompany to manage its UK PR and develop content for key countries. Check out our latest blog post for further details 👉 https://t.co/armkGMXb9c #pr
📢Early career researchers have been dramatically affected by COVID-19. Universities, funders and the whole scientific community ought to do more to support a generation capable of finding solutions to critical global challenges. Read our recommendations here ⬇️